Capex Related Published Studies
Well-designed clinical trials related to Capex (Fluocinolone Topical)
Randomized comparison of systemic anti-inflammatory therapy versus fluocinolone acetonide implant for intermediate, posterior, and panuveitis: the multicenter uveitis steroid treatment trial. [2011.10]
Fluocinolone acetonide intravitreal implant for diabetic macular edema: a 3-year multicenter, randomized, controlled clinical trial. [2011.08]
Long-term benefit of sustained-delivery fluocinolone acetonide vitreous inserts for diabetic macular edema. [2011.04]
Fluocinolone acetonide implantable device for diabetic retinopathy. [2011.03.01]
Sustained ocular delivery of fluocinolone acetonide by an intravitreal insert. [2010.07]
Evaluation of an intravitreal fluocinolone acetonide implant versus standard systemic therapy in noninfectious posterior uveitis. [2010.03]
Treatment of posterior uveitis with a fluocinolone acetonide implant: three-year clinical trial results. [2008.09]
A randomized controlled trial of the efficacy and safety of a fixed triple combination (fluocinolone acetonide 0.01%, hydroquinone 4%, tretinoin 0.05%) compared with hydroquinone 4% cream in Asian patients with moderate to severe melasma. [2008.09]
A randomized controlled trial of the efficacy and safety of a fixed triple combination (fluocinolone acetonide 0.01%, hydroquinone 4%, tretinoin 0.05%) compared with hydroquinone 4% cream in Asian patients with moderate to severe melasma. [2008.06.28]
Fluocinolone acetonide implant (Retisert) for noninfectious posterior uveitis: thirty-four-week results of a multicenter randomized clinical study. [2006.06]
Long-term follow-up results of a pilot trial of a fluocinolone acetonide implant to treat posterior uveitis. [2005.07]
Fluocinolone acetonide topical oil for scalp psoriasis. [2004.12]
Fluocinolone acetonide 0.01% in peanut oil: therapy for childhood atopic dermatitis, even in patients who are peanut sensitive. [2003.04]
Fluocinolone acetonide sustained drug delivery device to treat severe uveitis. [2000.11]
Efficacy of fluocinolone acetonide gel in the treatment of oral lichen planus. [2000.01]
Efficacy of topical retinoic acid compared with topical fluocinolone acetonide in the treatment of oral lichen planus. [1997.01]
Mometasone furoate ointment and cream 0.1 percent in treatment of psoriasis: comparison with ointment and cream formulations of fluocinolone acetonide 0.025 percent and triamcinolone acetonide 0.1 percent. [1988.11]
Well-designed clinical trials possibly related to Capex (Fluocinolone Topical)
Challenges in the design and implementation of the Multicenter Uveitis Steroid Treatment (MUST) Trial - lessons for comparative effectiveness trials. [2011.10.12]
Morphologic assessment for glaucoma in the Multicenter Uveitis Steroid Treatment (MUST) trial. [2011.08]
Validation of a photographic vitreous haze grading technique for clinical trials in uveitis. [2011.08]
Intranasal flunisolide treatment in patients with non-allergic rhinitis. [2011.04]
Effects of a novel formulation of fluocinonide 0.1% cream on skin barrier function in atopic dermatitis. [2011.02]
Sequential treatment with triple combination cream and intense pulsed light is more efficacious than sequential treatment with an inactive (control) cream and intense pulsed light in patients with moderate to severe melasma. [2011.02]
Low-fluence Q-switched neodymium-doped yttrium aluminum garnet laser for melasma with pre- or post-treatment triple combination cream. [2010.06]
The multicenter uveitis steroid treatment trial: rationale, design, and baseline characteristics. [2010.04]
The multicenter uveitis steroid treatment trial: rationale, design, and baseline characteristics. [2010.04]
High-dose inhaled flunisolide versus budesonide in the treatment of acute asthma exacerbations in preschool-age children. [2009.04]
Prevention of surgery in children with adenoidal hypertrophy treated with intranasal flunisolide: a 12-month follow-up. [2009.04]
A single-center, double-blind, randomized trial of the atrophogenic effects of fluocinonide cream 0.1% versus clobetasol propionate cream 0.05% in participants with corticosteroid-responsive dermatoses. [2008.06]
The effect of ceramide-containing skin care products on eczema resolution duration. [2008.01]
Intranasal flunisolide treatment in children with adenoidal hypertrophy. [2007.10]
Strength and endurance of the respiratory and handgrip muscles after the use of flunisolide in normal subjects. [2007.07]
A hydroquinone formulation with increased stability and decreased potential for irritation. [2007.06]
A comparison of triple combination cream and hydroquinone 4% cream for the treatment of moderate to severe facial melasma. [2007.03]
An open-label adrenal suppression study of 0.1% fluocinonide cream in pediatric patients with atopic dermatitis. [2006.12]
Long-term continuous efalizumab therapy in patients with moderate to severe chronic plaque psoriasis: updated results from an ongoing trial. [2006.04]
Inhaled flunisolide suppresses the hypothalamic-pituitary-adrenocortical axis, but has minimal systemic immune effects in healthy cats. [2006.01]
Efficacy of nebulized flunisolide combined with salbutamol and ipratropium bromide in stable patients with moderate-to-severe chronic obstructive pulmonary disease. [2006]
A large 12-month extension study of an 8-week trial to evaluate the safety and efficacy of triple combination (TC) cream in melasma patients previously treated with TC cream or one of its dyads. [2005.09]
Effects of drug treatment on inflammation and hyperreactivity of airways and on immune variables in cats with experimentally induced asthma. [2005.07]
The effect of two skin cleansing systems on moderate xerotic eczema. [2004.06]
A comparative study of punch grafting followed by topical corticosteroid versus punch grafting followed by PUVA therapy in stable vitiligo. [2004.01]
Asthma steroid pharmacogenetics: a study strategy to identify replicated treatment responses. [2004]
Effect of topical nasal corticosteroids on patients with chronic fatigue syndrome and rhinitis. [2003.09]
A randomized controlled trial of inhaled flunisolide in the management of acute asthma in children. [2003.09]
Efficacy and safety of a new triple-combination agent for the treatment of facial melasma. [2003.07]
Triple inhaled drug protocol for the treatment of acute severe asthma. [2003.06]
Comparison of high-dose inhaled flunisolide to systemic corticosteroids in severe adult asthma. [2002.10]
Multiple-dose proportionality study of flunisolide hydrofluoroalkane. [2002.09]
One-year trial on safety and normal linear growth with flunisolide HFA in children with asthma. [2002.06]
Systemic effect comparisons of six inhaled corticosteroid preparations. [2002.05.15]
A comparison of methods for assessing hypothalamic-pituitary-adrenal (HPA) axis activity in asthma patients treated with inhaled corticosteroids. [2002.03]
Single-dose study to compare the pharmacokinetics of HFA flunisolide and CFC flunisolide. [2002.02]
Flunisolide HFA vs flunisolide CFC: pharmacokinetic comparison in healthy volunteers. [2001.12]
Corticosteroids administered by nebulization to children with bronchial asthma. [2001.11]
Effective control of asthma with hydrofluoroalkane flunisolide delivered as an extrafine aerosol in asthma patients. [2001.11]
Suppression of hypothalamic-pituitary-adrenal axis activity with inhaled flunisolide and fluticasone propionate in adult asthma patients. [2001.11]
[Antiinflammatory effect of a topical corticosteroid: known brand versus generic drug] [2001.07]
Deposition and pharmacokinetics of flunisolide delivered from pressurized inhalers containing non-CFC and CFC propellants. [2001.06]
Randomized trial of inhaled flunisolide versus placebo among asthmatic patients discharged from the emergency department. [2000.11]
Efficacy of a steroid nasal spray compared with an antihistamine nasal spray in the treatment of perennial allergic rhinitis. [2000.07]
Pharmacokinetics of flunisolide administered via metered dose inhaler with and without a spacer device and following oral administration. [2000.05]
Exhaled nitric oxide in asthmatic children exposed to relevant allergens: effect of flunisolide. [2000.04]
Comparison of efficacy and safety between flunisolide/AeroChamber and budesonide/turbuhaler in patients with moderate asthma. AER-MD-04 Study Group. [2000.03]
Effectiveness and acceptability of a domiciliary multidrug inhalation treatment in elderly patients with chronic airflow obstruction: metered dose inhaler versus jet nebulizer. [2000.03]
Cost effectiveness of fluticasone propionate and flunisolide in the treatment of corticosteroid-naive patients with moderate asthma. [1999.11]
A controlled study on the effectiveness of loratadine in combination with flunisolide in the treatment of nonallergic rhinitis with eosinophilia (NARES). [1999.08]
Effects of the inhaled corticosteroids fluticasone propionate, triamcinolone acetonide, and flunisolide and oral prednisone on the hypothalamic-pituitary-adrenal axis in adult patients with asthma. [1999.02]
Topical corticosteroids in association with miconazole and chlorhexidine in the long-term management of atrophic-erosive oral lichen planus: a placebo-controlled and comparative study between clobetasol and fluocinonide. [1999.01]
Once-daily tazarotene gel versus twice-daily fluocinonide cream in the treatment of plaque psoriasis. [1998.05]
Lung deposition of fenoterol and flunisolide delivered using a novel device for inhaled medicines: comparison of RESPIMAT with conventional metered-dose inhalers with and without spacer devices. [1998.04]
Inhaled flunisolide for acute severe asthma. [1998.03]
Effects of low and high doses of inhaled flunisolide and triamcinolone acetonide on basal and dynamic measures of adrenocortical activity in healthy volunteers. [1998.03]
Six-week trial of nebulized flunisolide nasal spray: efficacy in young children with moderately severe asthma. [1997.12]
Mometasone furoate 0.1%-salicylic acid 5% ointment twice daily versus fluocinonide 0.05% ointment twice daily in the management of patients with psoriasis. [1997.07]
Allergic rhinitis in children: effects of flunisolide and disodium cromoglycate on nasal eosinophil cationic protein. [1997.03]
The effectiveness of once-daily dosing of inhaled flunisolide in maintaining asthma control. [1997.03]
[Controlled clinical comparative evaluation of fluticasone powder inhalation versus flunisolide dose aerosol in patients with mild to moderate asthma] [1997.01]
Efficient delivery to the lungs of flunisolide aerosol from a new portable hand-held multidose nebulizer. [1996.09]
New formulation of aqueous flunisolide nasal spray in the treatment of allergic rhinitis: comparative assessment of safety, tolerability, and efficacy. [1996.05]
Nebulized flunisolide in infants and young children with asthma: a pilot study. [1996.05]
A bioassay for topical and systemic effect of three inhaled corticosteroids. [1995.04]
Prolonged occlusion in the treatment of psoriasis: a clinical and immunohistologic study. [1995.04]
Comparative study of calcipotriene (MC 903) ointment and fluocinonide ointment in the treatment of psoriasis. [1994.11]
Comparative trial of acceptability of beclomethasone dipropionate and a new formulation of flunisolide. [1994.06]
Double-blind clinical trial of 0.05% clobetasol propionate (corrected from proprionate) ointment in orabase and 0.05% fluocinonide ointment in orabase in the treatment of patients with oral vesiculoerosive diseases. [1994.06]
Intranasal flunisolide spray as an adjunct to oral antibiotic therapy for sinusitis. [1993.12]
Comparative taste evaluation of aerosolized formulations of triamcinolone acetonide, flunisolide, and flunisolide with menthol. [1993.11]
Fluocinonide in an adhesive base for treatment of oral lichen planus. A double-blind, placebo-controlled clinical study. [1993.02]
[Ointment treatment of 1st degree hemorrhoids. Comparison of the effectiveness of a phytogenic preparation with two new ointments containing synthetic drugs] [1992.03.20]
A randomized prospective comparison of two methods of administering topical treatment in otitis externa. [1991.12]
A double-blind controlled comparison of generic and trade-name topical steroids using the vasoconstriction assay. [1991.02]
Double-blind evaluation of effectiveness and safety of flunisolide aerosol for treatment of bronchial asthma in children. [1990.11]
[Clinico-functional evaluation of flunisolide + salbutamol combination (VAL 679/A) vs salbutamol in pediatric patients] [1990.06]
Evaluation of symptom relief, nasal airflow, nasal cytology, and acceptability of two formulations of flunisolide nasal spray in patients with perennial allergic rhinitis. [1990.06]
Intrinsic potencies of novel thiol ester corticosteroids RS-85095 and RS-21314 as compared with clobetasol 17-propionate and fluocinonide. [1989.12]
A controlled clinical trial of a new formulation of betamethasone dipropionate cream in once-daily treatment of psoriasis. [1989.11]
Beclomethasone dipropionate versus flunisolide as topical steroid treatment in patients with perennial rhinitis. [1989.10]
Rhinomanometric evaluation of two nasal steroid sprays in rhinitis. [1989.10]
Double-blind comparison of a dithranol and steroid mixture with a conventional dithranol regimen for chronic psoriasis. [1988.11]
Comparative tolerability of two formulations of Rhinalar (flunisolide) nasal spray in patients with seasonal allergic rhinitis. [1988.10]
|
